• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一位病理学家对前列腺癌的看法。

A pathologist's view of prostatic carcinoma.

作者信息

Mostofi F K, Sesterhenn I A, Davis C J

机构信息

Department of Genitourinary Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000.

出版信息

Cancer. 1993 Feb 1;71(3 Suppl):906-32. doi: 10.1002/1097-0142(19930201)71:3+<906::aid-cncr2820711407>3.0.co;2-i.

DOI:10.1002/1097-0142(19930201)71:3+<906::aid-cncr2820711407>3.0.co;2-i
PMID:7679044
Abstract

In this article, the pathologic findings of carcinoma of the prostate were reviewed. Criteria were discussed for the pathologic diagnosis of prostatic carcinoma (PC), premalignant lesions, lesions that simulate PC, immunopathologic findings, special types of PC, effects of therapy on the prostate, and recent efforts to improve diagnostic and prognostic capabilities. The possible role of the study of nucleolar organizing regions was reported. A new method for demonstrating chromosomes in formaldehyde-fixed paraffin-embedded tissue was mentioned. The need for research in all aspects of the pathology of prostatic cancer was emphasized.

摘要

本文回顾了前列腺癌的病理检查结果。讨论了前列腺癌(PC)病理诊断的标准、癌前病变、疑似PC的病变、免疫病理检查结果、PC的特殊类型、治疗对前列腺的影响以及近期在提高诊断和预后能力方面所做的努力。报道了核仁组织区研究的可能作用。提及了一种在甲醛固定石蜡包埋组织中显示染色体的新方法。强调了对前列腺癌病理学各个方面进行研究的必要性。

相似文献

1
A pathologist's view of prostatic carcinoma.一位病理学家对前列腺癌的看法。
Cancer. 1993 Feb 1;71(3 Suppl):906-32. doi: 10.1002/1097-0142(19930201)71:3+<906::aid-cncr2820711407>3.0.co;2-i.
2
Pathology of carcinoma of the prostate.
Cancer. 1992 Jul 1;70(1 Suppl):235-53. doi: 10.1002/1097-0142(19920701)70:1+<235::aid-cncr2820701311>3.0.co;2-g.
3
Natural history of prostatic carcinoma: the pathologist's perspective.前列腺癌的自然史:病理学家的观点。
Recent Results Cancer Res. 2007;175:9-24. doi: 10.1007/978-3-540-40901-4_2.
4
Mucins in prostatic intra-epithelial neoplasia and prostatic carcinoma.前列腺上皮内瘤变和前列腺癌中的黏蛋白
Histopathology. 1993 Mar;22(3):271-4. doi: 10.1111/j.1365-2559.1993.tb00118.x.
5
[Prognostic factors in prostate cancer].[前列腺癌的预后因素]
Pathologe. 2005 Nov;26(6):433-43. doi: 10.1007/s00292-005-0792-z.
6
[Various immunohistochemical markers of precancer and variants of prostate cancer].
Arkh Patol. 1995 Jul-Aug;57(4):38-41.
7
Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase.用于前列腺特异性抗原和前列腺特异性酸性磷酸酶的商用免疫过氧化物酶试剂盒的评估。
Acta Pathol Microbiol Immunol Scand A. 1986 Jan;94(1):7-12. doi: 10.1111/j.1699-0463.1986.tb02957.x.
8
The differential diagnosis of prostatic carcinoma. Its distinction from premalignant and pseudocarcinomatous lesions of the prostate gland.前列腺癌的鉴别诊断。它与前列腺癌前病变及假癌性病变的区分。
Am J Clin Pathol. 1994 Jan;101(1):48-64. doi: 10.1093/ajcp/101.1.48.
9
A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.前列腺癌前病变和早期癌组织发生的理论依据。
Pathologica. 1994 Apr;86(2):128-41.
10
Correlation between immunohistochemical patterns and serum levels of PSA and PSAP in prostatic pathology: evaluation of 198 prostatic fine needle biopsies.前列腺病理学中免疫组化模式与血清前列腺特异性抗原(PSA)和前列腺特异性酸性磷酸酶(PSAP)水平的相关性:198例前列腺细针穿刺活检的评估
Anticancer Res. 1994 Jul-Aug;14(4A):1503-7.

引用本文的文献

1
Clinical, Histopathological, and Prognostic Characteristics of Patients with Prostate Cancer in Lubumbashi, Democratic Republic of Congo.刚果民主共和国卢本巴希前列腺癌患者的临床、组织病理学和预后特征
Prostate Cancer. 2020 Dec 9;2020:5286929. doi: 10.1155/2020/5286929. eCollection 2020.
2
Histopathology of Prostate Cancer.前列腺癌的组织病理学。
Cold Spring Harb Perspect Med. 2017 Oct 3;7(10):a030411. doi: 10.1101/cshperspect.a030411.
3
The role of metabolic imaging in radiation therapy of prostate cancer.代谢成像在前列腺癌放射治疗中的作用。
NMR Biomed. 2014 Jan;27(1):100-11. doi: 10.1002/nbm.3007. Epub 2013 Aug 12.
4
Current management of prostate cancer: dilemmas and trials.当前前列腺癌的治疗:困境与挑战。
Br J Radiol. 2012 Nov;85 Spec No 1(Spec Iss 1):S28-40. doi: 10.1259/bjr/13017671.
5
Intraobserver and interobserver reproducibility of WHO and Gleason histologic grading systems in prostatic adenocarcinomas.
Int Urol Nephrol. 1996;28(1):73-7. doi: 10.1007/BF02550141.
6
Proliferating cell nuclear antigen/cyclin in incidental carcinoma of the prostate.
Virchows Arch A Pathol Anat Histopathol. 1993;423(5):365-8. doi: 10.1007/BF01607149.